Molecular therapy for Myocardial disorders: Neurotensin prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 5.13 am

Molecular therapy for Myocardial disorders: Neurotensin prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 5.13 am

Molecular therapy for Myocardial disorders: Neurotensin prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 5.13 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Molecular therapy for Myocardial disorders:  Neurotensin prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 5.13 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation